dpp-4 inhibitors and glp-1 agonists Clinical Use of The pharmacology of DPP-4 inhibitors
Description
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion

Therefore, this compound seems to be not solely a new antidiabetic medication

Dunn, T

Lancet Diabetes Endocrinol

Common Side Effects of GLP-1 medications Gastrointestinal Side Effects The most frequently reported side effects of GLP-1 medications are gastrointestinal issues
